Dec, 2014
An integrative analysis of PIK3CA mutation, PTEN, and INPP4B expression in terms of trastuzumab efficacy in HER2-positive breast cancer.
PLoS One.
Aiko Sueta
(末田 愛子)
Modified on: 2019/12/27